Reporte de caso: Presentación clínica e importancia de coinfecciones durante pandemia por COVID-19 en pacientes con neoplasias malignas

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9. https://doi.org/10.1001/jama.2020.1585

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13. https://doi.org/10.1016/S0140-6736(20)30211-7

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382:1708‐20. https://doi.org/10.1056/NEJMoa2002032

Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020; S0923-7534(20)36383-3. https://doi.org/10.1016/j.annonc.2020.03.296

Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. The Lancet Oncology. 2009;10(6):589–97. https://doi.org/10.1016/S1470-2045(09)70069-5

Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020. Epub Ahead. https://doi.org/ 10.20944/preprints202002.0378.v1

Saavedra Trujillo CH. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020 24:1-102. https://doi.org/10.22354/in.v24i3.851

Instituto Nacional de Salud. Boletín Epidemiológico. Fecha de consulta: 23 de mayo de 2020. Disponible en: https://www.ins.gov.co/buscador-eventos/Paginas/Vista-Boletin-Epidemilogico.aspx

Anexo versión 11. Instituto Nacional de Salud. Instructivo para la vigilancia en salud pública intensificada de infección respiratoria aguda asociada al nuevo coronavirus 2019 (COVID-19). Fecha de consulta: 13 de mayo de 2020. Disponible en: https://www.ins.gov.co/Noticias/Coronavirus/Anexo_%20Instructivo%20Vigilancia%20COVID%20v11%2012052020.pdf

Weng TC, Chiu HYR, Chen SY, Shih FY, King CC, Fang CC. National retrospective cohort study to identify age-specific fatality risks of comorbidities among hospitalised patients with influenza-like illness in Taiwan. BMJ Open. 2019;9(6):e025276. http://dx.doi.org/10.1136/bmjopen-2018-025276

Kim YJ, Lee ES, Lee YS. High mortality from viral pneumonia in patients with cancer. Infect Dis (Lond). 2019;51(7):502–9. https://doi.org/10.1080/23744235.2019.1592217

Gosain R, Abdou Y, Singh A, Rana N, Puzanov I, Ernstoff MS. COVID-19 and Cancer: a Comprehensive Review. Curr Oncol Rep. 2020;22(5):53. https://doi.org/10.1007/s11912-020-00934-7.

Moschovas MC, Sighinolfi MC, Rocco B, Bhat S, Onol F, Rogers T, et al. Balancing the Effects of COVID-19 Against Potential Progression and Mortality in High-risk Prostate Cancer. Eur Urol.2020; S0302-2838(20)30260-8. https://doi.org/10.1016/j.eururo.2020.04.028.

Valentina S, Alessio P, Hans-Ulrich I. Benign COVID-19 in an immunocompromised cancer patient - The case of a married couple. Swiss Med Wkly. 2020;150(15–16). https://doi.org/10.4414/smw.2020.20246.

Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.The Lancet Oncology. 2020;21(3):335–7. https://doi.org/10.1016/S1470-2045(20)30096-6.

Montopoli M, Zumerle S, Vettor R, Rugge M, Zorzi M, Catapano C V, et al. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532). Ann Oncol. 2020; Epub ahead. https://doi.org/10.1016/j.annonc.2020.04.479

McCoy J, Wambier CG, Vano‐Galvan S, Shapiro J, Sinclair R, Müller Ramos P, et al. Racial Variations in COVID‐19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti‐Androgens a Potential Treatment for COVID‐19? J Cosmet Dermatol. 2020; Epub ahead. https://doi.org/10.1111/jocd.13455

Vilar-Compte D, Shah DP, Vanichanan J, Cornejo-Juarez P, Garcia-Horton A, Volkow P, et al. Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers. J Med Virol. 2018;90(1):50–60. https://doi.org/10.1002/jmv.24930

Choi SM, Boudreault AA, Xie H, Englund JA, Corey L, Boeckh M. Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood. 2011;117(19):5050–6. https://doi.org/10.1182/blood-2010-11-319186

Tai Y, Lee TC, Chang HL, Chen KT. Epidemiology and outcomes of hospitalization of influenza in the cancer population in Taiwan. J Cancer Res Clin Oncol. 2009;135(8):1061–6. https://doi.org/10.1007/s00432-009-0545-0

Mikulska M, Del Bono V, Gandolfo N, Dini S, Dominietto A, Di Grazia C, et al. Epidemiology of viral respiratory tract infections in an outpatient haematology facility. Ann Hematol. 2014;93(4):669–76. https://doi.org/10.1007/s00277-013-1912-0

Redelman-Sidi G, Sepkowitz KA, Huang CK, Park S, Stiles J, Eagan J, et al. 2009 H1N1 influenza infection in cancer patients and hematopoietic stem cell transplant recipients. J Infect. 2010;60(4):257–63. https://doi.org/10.1016/j.jinf.2010.01.009

Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncol. 2020; https://doi.org/10.1001/jamaoncol.2020.0980

Saad M, Hayajneh W, Mubarak S, Yousef I, Awad H, Elbjeirami W, et al. Clinical presentations and outcomes of influenza infection among hematology/oncology patients from a single cancer center: Pandemic and post-pandemic seasons. Scand J Infect Dis. 2014;46(11):770–8. https://doi.org/10.3109/00365548.2014.94328

Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020;epub ahead. https://doi.org/10.1093/cid/ciaa530

Wu X, Cai Y, Huang X, Yu X, Zhao L, Wang F, et al. Co-infection with SARS-CoV-2 and Influenza A Virus in Patient with Pneumonia, China. Emerg Infect Dis. 2020;26(6):1324-1326. https://dx.doi.org/10.3201/eid2606.200299

Touzard-Romo F, Tapé C, Lonks JR. Co-infection with SARS-CoV-2 and Human Metapneumovirus. R I Med J (2013). 2020;103(2):75–6. https://doi.org/10.1007/s00259-020-04735-9

Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection between SARS-CoV-2 and Other Respiratory Pathogens. JAMA; 2020. https://doi.org/10.1001/jama.2020.6266

Jiang S, Liu P, Xiong G, Yang Z, Wang M, Li Y, et al. Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children. Clinical Chemistry and Laboratory Medicine. De Gruyter; 2020. Epub ahead. https://doi.org/10.1515/cclm-2020-0434

Lin D, Liu L, Zhang M, Hu Y, Yang Q, Guo J, et al. Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients. Sci China Life Sci. 2020;63(4):606-609. https://doi.org/10.1007/s11427-020-1668-5

Cortiula F, Pettke A, Bartoletti M, Puglisi F, Helleday T. Managing COVID-19 in the oncology clinic and avoiding the distraction effect. 2020; 31(5):553-555 https://doi.org/10.1016/j.annonc.2020.03.286